Kawasaki disease: Etiology, pathogenesis, and treatment

Cleveland Clinic Journal of Medicine

Volumn 69, Issue SUPPL. 2, 2002, Pages

  Barron, Karyl S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ETANERCEPT; IMMUNOGLOBULIN; INFLIXIMAB; PENTOXIFYLLINE; PREDNISOLONE; IMMUNOGLOBULIN A; SUPERANTIGEN;

ANEURYSM; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONJUNCTIVITIS; CORONARY ARTERY DISEASE; ERYTHEMA; FEVER; HEART DISEASE; HUMAN; MITRAL VALVE REGURGITATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; SKIN EXFOLIATION; ANIMAL; BLOOD; CHILD; DISEASE MODEL; FEMALE; IMMUNE COMPLEX DISEASE; IMMUNOLOGY; INFANT; MALE; NEWBORN; PATHOPHYSIOLOGY; PLASMA CELL; PRESCHOOL CHILD; REVIEW;

ANIMALS; CHILD; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNE COMPLEX DISEASES; IMMUNOGLOBULIN A; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INFANT, NEWBORN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLASMA CELLS; SUPERANTIGENS;

EID: 0011977913     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.suppl_2.sii69     Document Type: Conference Paper

References (112)

1. Kawasaki T. Acute febrile mucocutaneous lymph node syndrome with accompanying specific peeling of the fingers and the toes {in Japanese}. Allergy 1967; 16:178-222.
2. Mason W, Takahashi M, Schneider T. Recurrence of Kawasaki disease in a large urban cohort in the United States. In: Proceedings of the Fourth International Symposium on Kawasaki Disease. Edited by Takahashi M, Taubert K. Dallas: American Heart Association, 1993:21-26.
3. Yanagawa H, Nakamura Y, Yashiro M, Hirose K. Results of 12 nationwide surveys of Kawasaki disease. In: Kawasaki Disease. Edited by Kato H. New York: Elsevier, 1995:3-14.
4. Fujita Y, Nakamura Y, Sakata H, Hara N, Kobayashi M, Nagai M, Yanagawa H, Kawasaki T. Kawasaki disease in families. Pediatrics 1989; 84:666-669.
5. Yashiro M, Nakamura Y, Hirose K, Yanagawa H. Surveillance of Kawasaki disease in Japan, 1984-1994. In: Kawasaki Disease. Edited by Kato H. New York: Elsevier, 1995:15-21.
6. Taubert K. Epidemiology of Kawasaki disease in the United States and worldwide. Prog Pediatr Cardiol 1997; 6:181-185.
7. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54:271-276.
8. Barron KS. Kawasaki disease in children. Curr Opin Rheumatol 1998; 10:29-37.
9. Dajani A, Taubert K, Gerber M, Shulman S, Ferrieri P, Freed M, Takahashi M, Bierman F, Karchmer A, Wilson W, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993; 87:1776-1780.
10. Usami H, Ryo S, Harada K, Okuni M. Mitral regurgitation in the acute phase of Kawasaki disease. In: Proceedings of the Fourth International Symposium on Kawasaki Disease. Edited by Takahashi M, Taubert K. Dallas: American Heart Association, 1993:370-373.
11. Nakano H, Nojima S, Saito A, Ueda K. High incidence of aortic regurgitation following Kawasaki disease. J Pediatr 1985; 107:59-63.
12. Akagi T, Rose V, Benson L, Newman A, Freedom R. Outcome of coronary artery aneurysm after Kawasaki disease. J Pediatr 1992; 121:689-694.
13. Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease; evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr 1992; 121:684-688.
14. Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: a pathological study. J Pediatr 1992; 100:225-231.
15. Suzuki A, Arakaki Y, Sugiyama H, Ono Y, Yamagishi M, Kimura K, Kamiya T. Observation of coronary arterial lesion due to Kawasaki disease by intravascular ultrasound. In: Kawasaki Disease. Edited by Kato H. New York: Elsevier, 1995:451-459.
16. Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 1986; 108:923-927.
17. Shibata M, Ezaki T, Hori M, Nagashima M, Morishima T. Isolation of a Kawasaki disease-associated bacterial sequence from peripheral blood leukocytes. Pediatr Int 1999; 41:467-473.
18. Chua PK, Nerurkar VR, Yu Q, Woodward CL, Melish MF, Yanigihara R. Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumonia. Pediatr Infect Dis J 2000; 19:477-479.
19. Burns JC, Geha RS, Schneeberger EE, Newburger JW, Rosen FS, Glezen LS, Huang AS, Natale J, Leung DYM. Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature 1986; 323:814-816.
20. Shulman ST, Rowley AH. Does Kawasaki disease have a retroviral aetiology? Lancet 1986; 2:545-546.
21. Melish ME, Marchette NJ, Kaplan JC, Kihara S, Ching D, Ho DD. Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndrome. Nature 1989; 337:288-290.
22. Rowley A, Castro B, Levy J, Sullivan J, Koup R, Fresco R, Shulman S. Failure to confirm the presence of a retrovirus in culture lymphocytes from patients with Kawasaki syndrome. Pediatr Res 1991; 29:417-419.
23. Kikuta H, Sakiyama Y, Matsumoto S, Hamada I, Yazaki M, Iwaki T, Nakano M. Detection of Epstein-Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein-Barr virus infection associated with Kawasaki disease-like coronary artery aneurysms. J Pediatr 1993; 123:90-92.
24. Culora GA, Moore IE. Kawasaki disease, Epstein-Barr virus and coronary artery aneurysms. Clin Pathol 1997; 50:161-163.
25. Marchette NJ, Melish M, Hicks R, Kihara S, Sam E, Ching D. Epstein-Barr virus and other herpesvirus infections in Kawasaki syndrome. J Infect Dis 1990; 161:680-684.
26. Normann E, Naas J, Gnarpe J, Backman H, Gnarpe H. Demonstration of Chlamydia pneumoniae in cardiovascular tissues from children with Kawasaki disease. Pediatr Infect Dis J 1999; 18:72-3.
27. Schrag SJ, Besser RE, Olson C, Burns JC, Arguin PM, Gimenez-Sanchez F, Stevens VA, Pruckler JM, Fields BS, Belay ED, Ginsberg M, Dowell SF. Lack of association between Kawasaki syndrome and Chlamydia pneumoniae infection: an investigation of a Kawasaki syndrome cluster in San Diego County. Pediatr Infect Dis J 2000; 19:17-22.
28. Strigl S, Kutlin A, Roblin PM, Shulman S, Hammerschlag MR. Is there an association between Kawasaki disease and Chlamydia pneumonia? J Infect Dis 2000; 181:2103, 2105.
29. Hsu YH, Wang YH, Hsu WY, Lee YP. Kawasaki disease characterized by erythema and induration of the Bacillus Calmette-Guerin and purified protein derivative inoculation sites. Pediatr Infect Dis J 1987; 6:576-578.
30. Kuniyuki S, Asada M. An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease. J Am Acad Dermatol 1997; 37:303-304.
31. Yokota S, Tsubaki K, Kuriyama T, Shimizu H, Ibe M, Mitsuda T, Aihara Y, Kosuge K, Nomaguchi H. Presence in Kawasaki disease of antibodies to mycobacterial heat-shock protein HSP 65 and autoantibodies to epitopes of human HSP65 cognate antigen. Clin Immunol Immunopathol 1993; 67:163-170.
32. Takeshita S, Kawase H, Yamamoto M, Fujisawa T, Sekine I, Yoshioka S. Increased expression of human 63-kd heat shock protein gene in Kawasaki disease determined by quantitative reverse transcription-polymerase chain reaction. Pediatr Res 1994; 35:179-183.
33. Patriarca PA, Rogers MF, Morens DM, Schonberger LB, Kaminski RM, Burns JC, Glode MP. Kawasaki syndrome: association with the application of rug shampoo. Lancet 1982; 2:578-580.
34. Daniels SR, Specker B. Association of rug shampooing and Kawasaki disease. J Pediatr 1991; 191:485-488.
35. Ushijima H, Park P, Yoshino K, Ohta K, Fujii R, Kobayashi N. Microorganisms in house dust mites in Kawasaki disease-a possible causal agent of the disease. Acta Paediatr Jpn 1983; 25:127-129.
36. Abe J, Kotzin BI, Judo K, Melish ME, Glode MP, Kohsaka T, Leung DYM. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci USA 1992; 89:4066-4070.
37. Abe J, Kotzin BL, Meissner C, Melish ME, Takahashi M, Fulton D, Romagne F, Malissen B, Leung DYM. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med 1993; 177:791-796.
38. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993; 342:1385-1388.
39. Curtis N, Zhen R, Lamb JR, Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child 1995; 72:308-311.
40. Leung DY, Meissner C, Fulton D, Schlievert PM. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome. J Clin Immunol 1995; 15:11S-17S.
41. Yamashiro Y, Nagata S, Oguchi S, Shimizu T. Selective increase of Vβ2 T cells in the small intestine mucosa in Kawasaki disease. Pediatr Res 1996; 39:264-266.
42. Masuda K, Takei S, Nomura Y, Imanaka H, Sameshima K, Yoshinaga M. Transient low T cell response to streptococcal pyrogenic exotoxin-C in patients with Kawasaki disease. Pediatr Res 1998; 44:27-31.
43. Yoshioka T, Matsutani T, Iwagami S, Toyosaki-Maeda T, Yutsudo T, Tsuruta Y, Suzuki H, Uemura S, Takeuchi T, Koike M, Suzuki R. Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology 1999; 96:465-472.
44. Sakaguchi M, Kato H, Nishiyori A, Sagawa K, Itoh K. Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-α) by Vβ2- or Vβ8- CD4+ T helper cells. Clin Exp Immunol 1993; 99:276-282.
45. Pietra BA, De Inocencio J, Giannini EH, Hirsch R. T cell receptor V beta family repertoire and T cell activation markers in Kawasaki disease. J Immunol 1994; 153:1881-1888.
46. Marchette NJ, Cao X, Kihara S, Martin J, Melish ME. Staphylococcal toxic shock syndrome toxin-1, one possible cause of Kawasaki syndrome? In: Kawasaki Disease. H Kato, ed. Amsterdam: Elsevier Science, 1995:149-155.
47. Tristani-Firouzi M, Kamanga-Sollo EIP, Sun S, Rocchini AP, Mathur A, Jyonouchi H. TCR Vβ gene family repertoire and humoral immunity in Kawasaki syndrome. In: Kawasaki Disease. H Kato, ed. Amsterdam: Elsevier Science, 1995:200-205.
48. Abe J, Takeda T, Ito Y, Noma S, Takeuchi N, Kobayashi N, Kohsaka T. TCR-Vβ specificity of Staphylococcus aureus isolated from acute patients with Kawasaki syndrome. In: Kawasaki Disease. H Kato, ed. Amsterdam: Elsevier Science, 1995:127-132.
49. Nishiyori A, Sakaguchi M, Kato H, Sagawa K, Itoh K, Miwa K, Igarashi H. Toxic shock syndrome toxin-1 and Vβ2 expression on T cells in Kawasaki disease. In: Kawasaki Disease. H Kato, ed. Amsterdam: Elsevier Science, 1995:139-143.
50. Todome Y, Ohkuni H, Mizuse M, Okibayashi F, Ohtani N, Suzuki H, Song C, Igarashi H, Harada K, Sakurai S, Kotani S. Superantigenic exotoxins production by isolates of Staphylococcus aureus from the Kawasaki syndrome patients and age-matched control children. J Med Microbiol 1995; 42:91-95.
51. Terai M, Miwa K, Williams T, Kabat W, Fukuyama M, Okajima Y, Igarashi H, Shulman ST. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis 1995; 172:558-561.
52. Deresiewicz RL, Flaxenburg J, Leng K, Kasper DL. Sequence of the toxic shock syndrome toxin gene borne by strains of Staphylococcus aureus isolated from patients with Kawasaki syndrome. Infect Immunol 1996; 64:3394-3396.
53. Morita A, Imada Y, Igarashi H, Yutsudo T. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease. Microbiol Immunol 1997; 41:895-900.
54. Choi I-H, Chwae Y-J, Shim W-S, Kim D-S, Kwon D-H, Kim J-D, Kim S-J. Clonal expansion of CD8+ T cells in Kawasaki disease. J Immunol 1997; 159:481-486
55. Mancia L, Wahlstrom J, Schiller B, Chini L, Blinder G, D'Argenio P, Gigliotti D, Wigzell H, Rossi P, Grunewald J. Characterization of the T-cell receptor V-β repertoire in Kawasaki disease. Scand J Immunol 1998; 48:443-449.
56. Nomura Y, Masuda K, Shinkoda Y, Sameshima K, Oku S. Twenty-five types of T-cell receptor Vβ family repertoire in patients with Kawasaki syndrome. Eur J Pediatr 1998; 157:981-986.
57. Barron K, DeCunto C, Montalvo J, Orson F, Lewis D. Abnormalities of immunoregulation in Kawasaki syndrome. J Rheumatol 1988; 15:1243-1249.
58. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, interleukin-2 receptor and interferon-gamma in Kawasaki disease involved coronary artery lesions. Clin Immunol Immunopathol 1990; 56:29-36.
59. Barron KS, Montalvo JF, Joseph AK, Hilario MO, Saadeh C, Gianinni EH, Orson FM. Soluble interleukin-2 receptors in children with Kawasaki syndrome. Arthritis Rheum 1990; 33:1371-1377.
60. Lin CY, Lin CC, Hwang B, Chiang BN. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur J Pediatr 1993; 152:309-312.
61. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, Kato H, Yabuta K. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988; 48:247-251.
62. Maury CPJ, Salo E, Pelkonen P. Elevated circulating tumor necrosis factor-α in patients with Kawasaki disease. J Lab Clin Med 1989; 113:651-654.
63. Lin CY, Lin CC, Hwang B, Chiang BN. The changes of interleukin-2, tumor necrotic factor and gamma-interferon production among patients with Kawasaki disease. Eur J Pediatr 1991; 150:179-182.
64. Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr 1992; 151:44-47.
65. Lin CY, Lin CC, Hwang B, Chiang BN. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992; 121:924-926.
66. Furukawa S, Matsubara T, Umezawa Y, Okumura K, Yabuta K. Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr 1994; 124:721-725.
67. Hirao JI, Nagayoshi I. Development of coronary artery lesions in Kawasaki disease patients in relation to plasma interferon-γ and interleukin-4 levels in the acute phase. Acta Paediatrica Japonica 1997; 39:293-295.
68. Takata Y, Seki S, Dobashi H, Takeshita S, Nakatani K, Kamezawa Y, Hiraide H, Sekine I, Yoshioka S. Inhibition of IL-12 synthesis of peripheral blood by mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implication of its effect on Kawasaki disease (KD). Clin Exp Immunol 1998; 114:311-319.
69. Maury CPJ, Salo E, Pelkonen P. Circulating interleukin 1β in patients with Kawasaki disease. N Engl J Med 1988; 319:1670-1671.
70. Ueno Y, Takano N, Kanegane H, Yokoi T, Yachie A, Miyawaki T, Taniguchi N. The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illness. Clin Exp Immunol 1989; 76:337-342.
71. Kim DS. Serum interleukin-6 in Kawasaki disease. Yonsei Med J 1992; 23:183-188.
72. Asano T, Ogawa S. Expression of IL-8 in Kawasaki disease. Clin Exp Immunol 2000; 122:514-519.
73. Leung KYM, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial cell activation and high-interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989; 2:1298-1302.
74. Lang BA, Silverman ED, Laxer RM, Lau AS. Spontaneous tumor necrosis factor production in Kawasaki disease. J Pediatr 1989; 115:939-943.
75. Suzuki H, Uemura S, Tone S, Iizuka T, Koike M, Hirayama K, Maeda J. Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-α and interleukin-1β by peripheral blood monocytes in the acute phase of Kawasaki disease. Eur J Pediatr 1996; 155:291-296.
76. Leung DYM, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, Pober JS. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 1986; 164:1958-1972.
77. Leung DYM, Collins T, Lapierre LA, Geha RS, Pober JS. Immunoglobulin M antibodies present in the acute phase Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 1986; 77:1428-1435.
78. Leung DY, Burns JC, Newburger JW, Geha RS. Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest 1987; 79:468-472.
79. Leung DYM, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial activation in the pathogenesis of Kawasaki disease. Trans Assoc Am Physicians 1989; 102:131-138.
80. Kaneko K, Savage COS, Pottinger BE, Shah V, Pearson JD, Dillon MJ. Antiendothelial cell antibodies can be cytotoxic to endothelial cells without cytokine pre-stimulation and correlate with ELISA antibody measurement in Kawasaki disease. Clin Exp Immunol 1994; 98:264-269.
81. Fujieda M, Oishi N, Kurashige T. Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment. Clin Exp Immunol 1997; 107:120-126.
82. Furukawa S, Imai K, Matiubara T, Yone K, Yachi A, Okumura K, Yabuta K< Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum 1992; 35:672-677.
83. Kim DS, Lee KY. Serum soluble E-selectin levels in Kawasaki disease. Scand J Rheumatol 1994; 23:283-286.
84. Takeshita S, Dobashi H, Nakatani K, Koike Y, Tsujimoto H, Hirayama K, Kawamura Y. Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol 1997; 108:446-450.
85. Takeshita S, Dobashi H, Nakatani K, Koike Y, Tsujimoto H, Hirayama K, Kawamura Y. Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol 1997; 108:446-450.
86. Rowley AH, Eckerly CA, Jack HM, Shulman ST, Baker SC. IgA PC in vascular tissue of a patient with Kawasaki syndrome. J Immunol 1997; 159:5946-5955.
87. Rowley AH, Shulman ST, Mask CA, Finn LS, Terai M, Baker SC, Galliani CA, Takahashi K, Naoe S, Kalelkar MB, Crawford SE. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney and coronary artery in acute Kawasaki disease. J Infect Dis 2000; 182:1183-1191.
88. Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001; 166:1334-1343.
89. Naoe S, Takahashi K, Yamada H, Wakayama M, Shibuya K, Nishijima M, Ichinose M. Analysis of Candida albicans extract causing angiitis in mice as an animal model of Kawasaki disease. In: Kawasaki Disease. H Kato, ed. New York: Elsevier Science, 1995: 284-285.
90. Onouchi Z, Tamiya H, Sakakibara Y, Fujimoto T, Ikuta K, Nagamatsu N, Kiyosawa N, Minaga T. Comparative study of the coronary arterial involvement in involvement in infant and adult rabbits with experimental allergic angiitis. Prog Clin Biol Res 1987; 250:529-530.
91. Liu Y, Onouchi Z, Ikuta K, Sakata K. Atherogenesis of the healed arteritis. In: Kawasaki Disease. H Kato, ed. New York: Elsevier Science, 1995:605-609.
92. Hogenesch H, Snyder PW, Scott-Moncreiff JCR, Glickman LT, Felsburg PJ. Interleukin-6 activity in dogs with juvenile polyarteritis syndrome: effect of corticosteroids. Clin Immunol Immunopathol 1995; 77:107-110.
93. Lehman TJA, Walker SM, Mahnovski V, McCurdy D. Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum 1985; 28:652-659.
94. Erahn E, Lehman TJ, Peacock DJ, Tang C, Banquerigo ML. Suppression of coronary vasculitis in a murine model of Kawasaki disease using an angiogenesis inhibitor. Clin Immunol 1999; 90:147-151.
95. Newburger J, Takahashi M, Burns J, Beiser A, Chung K, Duffy E, Glode M, Mason W, Reddy V, Sanders S, et al. Treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315:341-347.
96. Barron K, Murphy D, Silverman E, Ruttenberg H, Wright G, Franklin W, Goldberg S, Higashino S, Cox d, Lee M. Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin. J Pediatr 1990; 117:638-644.
97. Newburger J, Takahashi M, Beiser A, Burns J, Bastian J, Chung K, Colan S, Duffy E, Fulton D, Glode M, et al. A single infusion of gamma globulin as compared with four infusions in the treatment of Kawasaki syndrome. N Engl J Med 1991; 324:1633-1639.
98. Koren G, Schaffer F, Silverman E, et al. Determinants of low serum concentration of salicylates in patients with Kawasaki disease. J Pediatr 1988; 112:663-667.
99. Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994; 89:916-922.
100. Sundel R, Burns J, Baler A, Beiser A, Newburger J. Gamma globulin retreatment in Kawasaki disease. J Pediatr 1993; 123:657-659.
101. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and re-treatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998; 17:1144-1148.
102. Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery. Pediatrics 1979; 63:175-179.
103. th International Kawasaki Disease Symposium. Amsterdam: Elsevier Science BV, 1995:328-331.
104. Cremer H, Rieger C. Considerations on treatment in Kawasaki syndrome (KS). The Third International Kawasaki Disease Symposium Proceedings, Tokyo, Japan. 1988:297-300.
105. Kijima Y, Kamiya T, Sinuki A, Hirose D, Manabe H. A trial procedure to prevent an aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Jpn Circ J 1982; 46:1239-1242.
106. Wright DW, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996; 128:146-149.
107. Shinohara M, Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr 1999; 135:465-469.
108. Furukawa S, Matsubara T, Umegawa Y, Motohashi T, Ino T, Yabuta K. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease. Eur J Pediatr 1994; 153:663-667.
109. Kitamura S, Kameda Y, Seki T, Kawachi K, Endo M, Takeuchi Y, Kawasaki T, Kawashima Y. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease: a multicenter cooperative study. J Thorac Cardiovasc Surg 1994; 107:663-673.
110. Maeno Y, Sato N, Kato H. Long-term therapeutic strategies in patients with Kawasaki disease who suffered from old myocardial infarction. In: Kawasaki Disease. Edited by Kato H. New York: Elsevier, 1995:517-521.
111. Sugimura T, Kato H, Inoue O, Sato N, Akagi T, Karue T, Hashino K, Kiyomatsu Y. Long-term consequences of Kawasaki disease: serial coronary angiography and 10-20 years follow-up study. In: Kawasaki Disease. Edited by Kato H, New York: Elsevier, 1995:574-579.
112. Koutlas TC, Wernovsky G, Bridges ND, Suh EJ, Godinez RI, Nicolson SC, Spray TL, Gaynor JW. Orthotopic heart transplantation for Kawasaki disease after rupture of a giant coronary artery aneurysm. J Thorac Cardiovasc Surg 1997; 113:217-218.